• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Engelhard Corporation

Engelhard Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients with Rare Form of Blood Disease

    Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients with Rare Form of Blood Disease

  2. Colombia Stocks Rise on Higher Crude Oil Prices; Peso Gains

    Colombia Stocks Rise on Higher Crude Oil Prices; Peso Gains

  3. A.M. Best Affirms Ratings of London General Insurance Company Ltd and London General Life Company Ltd

    A.M. Best Affirms Ratings of London General Insurance Company Ltd and London General Life Company Ltd

  4. Fitch Affirms Prudential's Commercial Mortgage Pass-through Certificates, Series 1999-NRF1

    Fitch Affirms Prudential's Commercial Mortgage Pass-through Certificates, Series 1999-NRF1

  5. Quadrise Fuels Signs Latin America Memorandum with Ecopetrol, Nexidea

    Quadrise Fuels Signs Latin America Memorandum with Ecopetrol, Nexidea

  6. Ecopetrol Announces Hydrocarbons Discovery in Colombia

    Ecopetrol Announces Hydrocarbons Discovery in Colombia

  7. Intelsat Announces Pricing of Senior Notes

    Intelsat Announces Pricing of Senior Notes

  8. Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021

    Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021

  9. CORRECTING and REPLACING InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 23rd

    CORRECTING and REPLACING InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 23rd

  10. Colombia's Ecopetrol Sees Shares Fall to Lowest in 18 Months

    Colombia's Ecopetrol Sees Shares Fall to Lowest in 18 Months

123
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.